|
1
|
Hinojosa de la Garza OR, Sanín LH, Montero
Cabrera ME, et al: Lung cancer mortality and radon concentration in
a chronically exposed neighborhood in Chihuahua, Mexico: a
geospatial analysis. Scientific World Journal. 2014:9353802014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, et al: Global
cancer statistics. 2012. CA Cancer J Clin. Feb 4–2015.(Epub ahead
of print).
|
|
3
|
Fidias P and Novello S: Strategies for
prolonged therapy in patients with advanced non-small-cell lung
cancer. J Clin Oncol. 28:5116–5123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen MH, Cortazar P, Justice R and Pazdur
R: Approval summary: Pemetrexed maintenance therapy of
advanced/metastatic nonsquamous, non-small cell lung cancer
(NSCLC). Oncologist. 15:1352–1358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bareschino MA, Schettino C, Rossi A, et
al: Treatment of advanced non small cell lung cancer. J Thorac Dis.
3:122–133. 2011.PubMed/NCBI
|
|
6
|
Leighl NB: Treatment paradigms for
patients with metastatic non-small-cell lung cancer: First-,
second-, and third-line. Curr Oncol. 19:S52–S58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sangha R, Price J and Butts CA: Adjuvant
therapy in non-small cell lung cancer: Current and future
directions. Oncologist. 15:862–872. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ost D, Goldberg J, Rolnitzky L and Rom WN:
Survival after surgery in stage IA and IB non-small cell lung
cancer. Am J Respir Crit Care Med. 177:516–523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Riquet M, Arame A and Mordant P: Visceral
pleural invasion: a prognostic factor beginning with small size and
increasing with the progression of lung cancer. Ann Thorac Surg.
97:3832014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Meerbeeck JP and Janssens A: The
seventh tumour-node-metastasis staging system for lung cancer:
Sequel or prequel? Europ J Cancer. Suppl 11:150–158. 2013.
View Article : Google Scholar
|
|
11
|
Detterbeck FC, Boffa DJ and Tanoue LT: The
new lung cancer staging system. Chest. 136:260–271. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho S, Park TI, Lee EB and Son SA: Poor
Prognostic Factors in Surgically Resected Stage I Non-small Cell
Lung Cancer: Histopathologic and Immunohistochemical Analysis.
Korean J Thorac Cardiovasc Surg. 45:101–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park SY, Lee JG, Kim J, et al: Efficacy of
platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small
cell lung cancer. J Cardiothorac Surg. 8:1512013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawase A, Yoshida J, Miyaoka E, et al:
Visceral pleural invasion classification in non-small-cell lung
cancer in the 7th edition of the tumor, node, metastasis
classification for lung cancer: validation analysis based on a
large-scale nationwide database. J Thorac Oncol. 8:606–611.
2013.PubMed/NCBI
|
|
15
|
Hattori A, Suzuki K, Matsunaga T, et al:
Visceral pleural invasion is not a significant prognostic factor in
patients with a part-solid lung cancer. Ann Thorac Surg.
98:433–438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Byrne KJ, Barr MP and Gray SG: The role
of epigenetics in resistance to Cisplatin chemotherapy in lung
cancer. Cancers Basel. 3:1426–1453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wangpaichitr M, Wu C, You M, et al: N',
N'-Dimethyl-N', N'-bis(phenylcarbonothioyl) Propanedihydrazide
(Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer
Cells through Reactive Oxygen Species (ROS). Cancers Basel.
1:23–38. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu XX and Kakehi Y: Enhancement of
lexatumumab-induced apoptosis in human solid cancer cells by
Cisplatin in caspase-dependent manner. Clin Cancer Res.
15:2039–2047. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanborn RE: Cisplatin versus carboplatin
in NSCLC: Is there one “best” answer. Curr Treat Options Oncol.
9:326–342. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang A: Chemotherapy, chemoresistance and
the changing treatment landscape for NSCLC. Lung Cancer. 71:3–10.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mudiam MK, Chauhan A, Jain R, et al:
Molecularly imprinted polymer coupled with dispersive liquid-liquid
microextraction and injector port silylation: a novel approach for
the determination of 3-phenoxybenzoic acid in complex biological
samples using gas chromatographytandem mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci. 945–946:23–30. 2014.
View Article : Google Scholar
|
|
22
|
Hoofnagle AN and Roth MY: Clinical review:
Improving the measurement of serum thyroglobulin with mass
spectrometry. J Clin Endocrinol Metab. 98:1343–1352. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gosetti F, Mazzucco E, Gennaro MC and
Marengo E: Ultra high performance liquid chromatography tandem mass
spectrometry determination and profiling of prohibited steroids in
human biological matrices. A review. J Chromatogr B Analyt Technol
Biomed Life Sci. 927:22–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gouveia MJ, Brindley PJ, Santos LL, et al:
Mass spectrometry techniques in the survey of steroid metabolites
as potential disease biomarkers: A review. Metabolism.
62:1206–1217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bielawski J, Szulc ZM, Hannun YA and
Bielawska A: Simultaneous quantitative analysis of bioactive
sphingolipids by high-performance liquid chromatographytandem mass
spectrometry. Methods. 39:82–91. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Teng Z, Zhang Y, et al: High
performance liquid chromatographytandem mass spectrometric
determination of resveratrol and its metabolites in rat tissues.
Anal Lett. 43:557–569. 2010. View Article : Google Scholar
|
|
27
|
Chow TW, Szeitz A, Rurak DW and Riggs KW:
A validated enantioselective assay for the simultaneous
quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in
ovine plasma using liquid chromatography with tandem mass
spectrometry (LC/MS/MS). J Chromatogr B Analyt Technol Biomed Life
Sci. 879:349–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nordberg H, Jerndal G and Thompson RA:
Direct injection of lipophilic compounds in the organic phase from
liquid-liquid extracted plasma samples onto a reversed-phase
column. Bioanalysis. 3:1963–1973. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haam SJ, Park IK, Paik HC, et al: T-stage
of non-small cell lung cancer directly invading an adjacent lobe.
Eur J Cardiothorac Surg. 42:807–810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Torii I, Hashimoto M, Terada T, et al:
Well-differentiated papillary mesothelioma with invasion to the
chest wall. Lung Cancer. 67:244–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
